Category Archives : Custom Blog

Collaboration for Innovation

Collaboration is key to innovation in health care. By fusing together disparate resources and diverse skillsets and perspectives, we can   Read More

Ambitions of the World’s Largest Pragmatic Clinical Trial in COPD

Pragmatic clinical trials (PCTs) promise to address much of healthcare’s urgent need for real-world evidence to inform and improve decision-making   Read More

The Value of Pragmatic Trials to Regulators

There rarely exists a one-size-fits-all solution. It is true socially, politically and it is certainly true in healthcare especially when   Read More

Mastering Colony Stimulating Factor Use among Lung Cancer Patients Receiving Chemotherapy

It’s up to oncologists and their patients to make many, often tough, treatment decisions. For those treating patients receiving chemotherapy,   Read More

A Real-World Solution for an Unsustainable Health System

The BIO International Conference presents the global biotech industry with many growth opportunities. From BIO programs and initiatives to BIO   Read More

The Value of Pragmatic Trials to Clinicians

A reliance on real-world evidence for optimal decisions Clinicians are always striving to improve the quality and the precision of   Read More

A New Day in Healthcare Research

On May 20th, the international HEOR community of roughly 4,000 stakeholders from more than 80 countries will fill the Hynes   Read More

The Value of Pragmatic Trials to Life Science Product Developers

The need for higher levels of real-world evidence Healthcare stakeholders are increasingly demanding higher levels of real-world evidence. As the   Read More

HealthCore: 20 Years of Real-World Evidence

CT Scans in Pediatric Patients with Headache While headaches are very common in children and adolescents, many parents fear the   Read More

HealthCore: 20 Years of Real-World Evidence

Opioid Use Among Adolescent Patients Treated for Headache HealthCore has been developing actionable real-world evidence (RWE) for regulators, payers and   Read More